Medtronic Evolut™ EXPAND TAVR I Feasibility Study

Stopped early · Not applicable

Conditions studied: Aortic Valve Stenosis

In brief

The purpose of the study is to obtain safety and effectiveness data of the Medtronic Evolut™ PRO+ TAVR System for the treatment of severe, asymptomatic aortic stenosis.

Key facts

Study ID

NCT04639258

Run by

Medtronic Cardiovascular

People needed

11

Starts

2021-05-28

Expected to finish

2022-06-07

Last updated by the study team

2024-01-10

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Los Robles Hospital & Medical Center — Thousand Oaks, California, United States
• Northwell Health — Manhasset, New York, United States
• UPMC Pinnacle Harrisburg Campus — Wormleysburg, Pennsylvania, United States
• Aurora Saint Luke's Medical Center — Milwaukee, Wisconsin, United States
• The Alfred Hospital — Melbourne, Australia
• IUCPQ — Québec, Canada
• Rabin Medical Center — Petah Tikva, Israel
• Waikato Hospital — Hamilton, New Zealand

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.